These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 7913936)

  • 21. [Molecular diagnosis of multiple type 2 endocrine neoplasia].
    Amosenko FA; Pushkash K; Frilling A; Kozlova VN; Liubchenko LN; Kazubskaia TP; Brelysh KE; Gar'kavtseva RF; Kalinin VN
    Vestn Ross Akad Med Nauk; 2001; (2):34-7. PubMed ID: 11338505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations in the cysteine-rich region of the RET proto-oncogene in patients diagnosed as having sporadic medullary thyroid carcinoma.
    Kimura T; Yoshimoto K; Yokogoshi Y; Saito S
    Endocr J; 1995 Aug; 42(4):517-25. PubMed ID: 8556059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic and MEN 2A de novo mutations identified in the RET proto-oncogene by screening of sporadic MTC:s.
    Zedenius J; Wallin G; Hamberger B; Nordenskjöld M; Weber G; Larsson C
    Hum Mol Genet; 1994 Aug; 3(8):1259-62. PubMed ID: 7987299
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Germline RET mutations in MEN 2A and FMTC and their detection by simple DNA diagnostic tests.
    Xue F; Yu H; Maurer LH; Memoli VA; Nutile-McMenemy N; Schuster MK; Bowden DW; Mao J; Noll WW
    Hum Mol Genet; 1994 Apr; 3(4):635-8. PubMed ID: 7915165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.
    Tessitore A; Sinisi AA; Pasquali D; Cardone M; Vitale D; Bellastella A; Colantuoni V
    J Clin Endocrinol Metab; 1999 Oct; 84(10):3522-7. PubMed ID: 10522989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of minute medullary thyroid carcinoma in multiple endocrine neoplasia 2A families first diagnosed by DNA analysis of RET proto-oncogene mutations: a case report.
    Yamashita T; Lihara M; Okamoto J; Kanbe M; Ito Y; Kawakami M; Egawa S; Yamaguchi K; Obara T
    Jpn J Clin Oncol; 1997 Feb; 27(1):42-5. PubMed ID: 9070340
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. "Study Group Multiple Endocrine Neoplasia Austria (SMENA)".
    Fink M; Weinhüsel A; Niederle B; Haas OA
    Int J Cancer; 1996 Aug; 69(4):312-6. PubMed ID: 8797874
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predictive DNA testing and prophylactic thyroidectomy in patients at risk for multiple endocrine neoplasia type 2A.
    Wells SA; Chi DD; Toshima K; Dehner LP; Coffin CM; Dowton SB; Ivanovich JL; DeBenedetti MK; Dilley WG; Moley JF
    Ann Surg; 1994 Sep; 220(3):237-47; discussion 247-50. PubMed ID: 7916559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Point mutation of the RET proto-oncogene in the TT human medullary thyroid carcinoma cell line.
    Carlomagno F; Salvatore D; Santoro M; de Franciscis V; Quadro L; Panariello L; Colantuoni V; Fusco A
    Biochem Biophys Res Commun; 1995 Feb; 207(3):1022-8. PubMed ID: 7864888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A.
    Mulligan LM; Kwok JB; Healey CS; Elsdon MJ; Eng C; Gardner E; Love DR; Mole SE; Moore JK; Papi L
    Nature; 1993 Jun; 363(6428):458-60. PubMed ID: 8099202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas.
    Zedenius J; Larsson C; Bergholm U; Bovée J; Svensson A; Hallengren B; Grimelius L; Bäckdahl M; Weber G; Wallin G
    J Clin Endocrinol Metab; 1995 Oct; 80(10):3088-90. PubMed ID: 7559902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adrenal and extra-adrenal pheochromocytomas in a family with germline RET V804L mutation.
    Nilsson O; Tisell LE; Jansson S; Ahlman H; Gimm O; Eng C
    JAMA; 1999 May; 281(17):1587-8. PubMed ID: 10235148
    [No Abstract]   [Full Text] [Related]  

  • 33. Mutation analysis of the c-mos proto-oncogene and the endothelin-B receptor gene in medullary thyroid carcinoma and phaeochromocytoma.
    Eng C; Foster KA; Healey CS; Houghton C; Gayther SA; Mulligan LM; Ponder BA
    Br J Cancer; 1996 Aug; 74(3):339-41. PubMed ID: 8695346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the ret proto-oncogene in human medullary thyroid carcinomas and pheochromocytomas of MEN 2A.
    Miya A; Yamamoto M; Morimoto H; Tanaka N; Shin E; Karakawa K; Toyoshima K; Ishizaka Y; Mori T; Takai S
    Henry Ford Hosp Med J; 1992; 40(3-4):215-9. PubMed ID: 1362408
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid, nonradioactive screening for mutations in exons 10, 11, and 16 of the RET protooncogene associated with inherited medullary thyroid carcinoma.
    Siegelman M; Mohabeer A; Fahey TJ; Tomlinson G; Mayambala C; Jafari S; Noll WW; Thibodeau SN; Dawson DB
    Clin Chem; 1997 Mar; 43(3):453-7. PubMed ID: 9068588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Analysis of mutations in the RET proto-oncogene in patients with medullary thyroid tumor].
    Amosenko FA; Brzhezovskiĭ VZh; Liubchenko LN; Shabanov MA; Kozlova VM; Vanushko VE; Kazubskaia TP; Gar'kavtseva RF; Kalinin VN
    Genetika; 2003 Jun; 39(6):847-54. PubMed ID: 12884527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of RET mutations in multiple endocrine neoplasia type 2a and familial medullary thyroid carcinoma by denaturing gradient gel electrophoresis.
    Peacock ML; Borst MJ; Sweet JD; Decker RA
    Hum Mutat; 1996; 7(2):100-4. PubMed ID: 8829625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the RET proto-oncogene in sporadic hyperparathyroidism and in hyperparathyroidism of multiple endocrine neoplasia type 2.
    Pausova Z; Soliman E; Amizuka N; Janicic N; Konrad EM; Arnold A; Goltzman D; Hendy GN
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2711-8. PubMed ID: 8675600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mutations in the RET protooncogene in Japanese and Chinese sporadic medullary thyroid carcinomas.
    Shan L; Nakamura M; Nakamura Y; Utsunomiya H; Shou N; Jiang X; Jing X; Yokoi T; Kakudo K
    Jpn J Cancer Res; 1998 Sep; 89(9):883-6. PubMed ID: 9818022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pheochromocytoma and medullary thyroid carcinoma: a new genotype-phenotype correlation of the RET protooncogene 891 germline mutation.
    Jimenez C; Habra MA; Huang SC; El-Naggar A; Shapiro SE; Evans DB; Cote G; Gagel RF
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4142-5. PubMed ID: 15292360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.